Source Data presented at PCR London Valves 2024 showed that caval valve implantation (CAVI) with the TricValve® system demonstrates an acceptable safety profile and significant clinical benefits in highly comorbid patients with severe tricuspid regurgitation (TR), according to the TricBicaval registry’s one-year findings.  Severe TR poses

In this short summary, Hon. Prof. Dr. Katharina Kiss talks about what you need to know about tricuspid regurgitation and current therapy options. Read Here

In February 2018, a new article by Professor Lauten et al was published: Interventional Treatment of Severe Tricuspid Regurgitation. Early Clinical Experience in a Multicenter, Observational, First-in-Man Study. Transcatheter caval valve implantation is under evaluation as a treatment option for inoperable patients with severe tricuspid